Circulating tumor DNA sequencing of gastroesophageal adenocarcinoma.

PURPOSE: Gastroesophageal adenocarcinoma (GEA) has a poor prognosis and few therapeutic options. Utilizing a 73-gene plasma-based next-generation sequencing (NGS) cell-free circulating tumor DNA (ctDNA-NGS) test, we sought to evaluate the role of ctDNA-NGS in guiding clinical decision-making in GEA....

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Clin Cancer Res
Prif Awduron: Maron, Steven B., Chase, Leah M., Lomnicki, Samantha, Kochanny, Sara, Moore, Kelly L., Joshi, Smita S., Landron, Stacie, Johnson, Julie, Kiedrowski, Lesli A., Nagy, Rebecca J., Lanman, Richard B., Kim, Seung Tae, Lee, Jeeyun, Catenacci, Daniel V.T.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2019
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6891164/
https://ncbi.nlm.nih.gov/pubmed/31427281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-1704
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg